Totally implantable venous-access ports: local problems and extravasation injury
- 1 November 2002
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 3 (11), 684-692
- https://doi.org/10.1016/s1470-2045(02)00905-1
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Indications and complications of intravenous devices for chemotherapyCurrent Opinion in Oncology, 2000
- Complications Related to Indwelling Caval Catheters on a Gynecologic Oncology ServiceGynecologic Oncology, 1998
- Totally implantable central venous access ports for long-term chemotherapy A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 daysAnnals Of Oncology, 1998
- Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port SystemsWorld Journal of Surgery, 1998
- Subcutaneously implanted central venous access devices in cancer patientsCancer, 1997
- Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.Journal of Clinical Oncology, 1996
- CATHETER-RELATED COMPLICATIONS OF CANCER THERAPYInfectious Disease Clinics of North America, 1996
- Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted portsCancer, 1993
- Long-term central venous catheters: Issues for careSeminars in Oncology Nursing, 1992
- Totally implantable venous access system for cyclic administration of cytotoxic chemotherapyThe American Journal of Surgery, 1984